CSL BEHRING LLC for CSL BEHRING LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Preserving Access to Orphan Drugs Act--Orphan Drugs Exclusion from the Branded Annual Pharmaceutical Fee
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
| DENNIS JACKMAN | — |
Health Issues HCR
H.R. 4724--The Medicare IVIG Access Enhancement Act--Legislation that would create a home infusion benefit under Medicare Part B for intravenous immunoglobulin (IVIG) when used in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). Educating congressional staff specific to the value of drug therapies (drug pricing, value, access to therapies, etc.) as part of Administration drug pricing blueprint and request for information. CMS memo re: Medicare Advantage plans authorized to employ step therapy for Part B drugs--Educating congressional staff as to the access concerns this new policy will have for patients reliant on Part B therapies NIH Appropriations funding/DoD Medical Research funding - specific to hereditary angioedema FY 2019 NIH Appropriations - seeking congressional letter identifying NIH funding spent on hereditary angioedema/maintaining hereditary angioedema on the list of conditions for the Dept. of Defense Peer Reviewed Medical Research Program Resolution to Affirm the Importance of the Orphan Drug Act--Building support for introduction of a resolution to affirm the importance of the Orphan Drug Act
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
Government Issues GOV
S. 2039/HR 4170 Disclosing Foreign Influence Act--US Lobbying registration requirements for international companies
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIA GRANT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.